Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Raghavendra H.L

Raghavendra H.L
Raghavendra H.L
Director, Associate Professor,
School of Medicine,
Wollega University,
Nekemte,Ethiopia.

Biography

Raghavendra HL, completed his PhD in Biochemistry from Kuvempu University, Karnataka, India. Currently serving as Associate Professor in College of Health Sciences and Publication and Dissemination Director of Wollega University, Nekemte, Ethiopia. He received 3 Outstanding Presentation Award from International Conferences and awarded with best employer of Wollega University for 5 times. He is also the Life Member various scientific societies, Editor in Chief and Advisory Board member for more than 8 journals. He got sanctioned with more than 10 research projects. He published more than 85 articles, organizing secretary/member for more than 15 conferences and presented paper in more than 30 national and international conferences. He chaired/co-chaired a session for 8 national/international conferences. He also worked as Analytical Chemistr, Chemist and Inspector, Project fellow under UGC major research project, Scientist and Assistant Professor at Micro Labs Ltd., Caleb Brett India Pvt. Ltd., Kuvempu University, Bioneeds India Pvt. Ltd., Mallige College of Pharmacy respectively. His research interests include Phytochemistry, Pharmacology, Diabetes, Oxidative Stress, Bioavailability, Pharmacokinetics, Anticancer Drug Action, Drug Discovery and Delivery and Toxicology.

Research Interest

Publications

Strategies and Challenges of Structure-Based Drug Design and Remodelling Structure-Based Drug Design Using Machine Learning

Raghavendra H.L
: J Cell Mol Pharmacol,06:112
Relevant Topics
Top